TY - JOUR
TI - Elotuzumab for multiple myeloma
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2022
ET - 2022/07/07
VL - 45
IS - 4
SP - 138
EP - 139
DO - 10.18773/austprescr.2022.040
LA - eng
UR - https://australianprescriber.tg.org.au/articles/elotuzumab-for-multiple-myeloma.html
KW - elotuzumab
KW - Empliciti
KW - multiple myeloma
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -